Epidemiologic and economic burden of HPV diseases in Spain: implication of additional 5 types from the 9-valent vaccine.

López, Noelia; Torné, Aureli; Franco, Agustín; San-Martin, María; Viayna, Elisabet; Barrull, Carmen; Perulero, Nuria

López, Noelia; Torné, Aureli; Franco, Agustín; San-Martin, María; Viayna, Elisabet; Barrull, Carmen; Perulero, Nuria.

Afiliação

López N; 1Medical Affairs, MSD, Madrid, Spain.
Torné A; 2Gynecologic Oncology Unit, Institut Clinic of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Faculty of Medicine, University of Barcelona, Barcelona, Spain.
Franco A; 3Diagnostic Unit of Urology, Clinic Institute of Nephrology and Urology (ICNU) Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain.
San-Martin M; 1Medical Affairs, MSD, Madrid, Spain.
Viayna E; Health Economics and Outcomes Research, Real World Insights, IQVIA, Barcelona, Spain.
Barrull C; Health Economics and Outcomes Research, Real World Insights, IQVIA, Barcelona, Spain.
Perulero N; Health Economics and Outcomes Research, Real World Insights, IQVIA, Barcelona, Spain.

Infect Agent Cancer ; 13: 15, 2018.

Article em En | MEDLINE | ID: mdl-29743937

Palavras-chave

Burden of disease; Cancer; Human papillomavirus; Precancerous lesions; Vaccine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation Idioma: En Revista: Infect Agent Cancer Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Espanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google